Brief: Theraclion/‍SONOVEIN®: Results Of First US Trial

Theraclion SA

30/01/2023 17:32

Jan 30 (Reuters) - Theraclion SA  ALTHER.PA :
    * THERACLION ANNOUNCES RESULTS OF FIRST US TRIAL
    * STUDY COMPLIANCE WAS 100%, MEANING ALL 80 VISITS WERE
COMPLETED
AND TIMELY, NONE LOST TO FOLLOW-UP OR MISSED VISITS
    * ABOLITION OF VENOUS REFLUX, AS MEASURED BY DUPLEX
ULTRASOUND,
WAS ACHIEVED IN 95% OF CASES

Source text for Eikon:  ID:nBw20KZM9a 
Further company coverage:  ALTHER.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))